For RCC subtypes, high-stage ccRCC patients had a median survival of 43.96 months, while the high NPC1L1/high-stage group had a shorter survival of 37.25 months (Figure 5C,D). The gene discussed is NPC1L1; the disease is nonpapillary renal cell carcinoma.